Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) Could Outperform in 2H19 for 4 Reasons

July 12, 2019 8:22 AM
Oppenheimer analyst Hartaj Singh reiterated an Outperform rating and $85.00 price target on Gilead Sciences (NASDAQ: GILD) and believes shares ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments